BCAT1 and colorectal carcinoma: Comparative studies between methylated BCAT1 and IKZF1 DNA blood tests and CEA for recurrent CRC have shown that BCAT1/IKZF1 exhibits higher sensitivity for recurrence detection, with a probability of positive recurrence twice that of CEA [48–50].